Raymond James on February 26, 2026 maintained an Outperform rating on Crescent Capital BDC, Inc. (CCAP) while cutting its price target to $14. This CCAP analyst rating keeps a positive tilt for the stock but signals lower near-term upside. The note, reported by StreetInsider, showed no immediate price move at release and listed price change as 0.0% ($0.0). We review the rating action, the new $14 target, and what it means for investors given CCAP’s current market cap of $468,510,304.

CCAP analyst rating: Raymond James maintained Outperform on Feb 26, 2026

Raymond James on Feb 26, 2026 at 04:05 PM maintained an Outperform rating for Crescent Capital BDC, Inc. (CCAP). The firm left the positive rating in place but lowered its price target to $14, according to StreetInsider source.

CCAP analyst rating: Price target cut to $14 and immediate market reaction

Raymond James reduced its target to $14, reflecting lower expected upside from current levels. StreetInsider reported no immediate price move at the time, showing 0.0% change on the analyst note release.

CCAP analyst rating: What the maintained rating means for investors

A maintained Outperform means Raymond James still sees relative gains versus peers, but the lower $14 target narrows the expected return. Investors should view the note as a mix of continued confidence and more cautious near-term expectations.

CCAP analyst rating: Historical analyst coverage and context

Recent coverage for Crescent Capital BDC, Inc. (CCAP) has been limited with Raymond James providing the latest formal note. The firm’s action keeps CCAP on a favorable watchlist while signaling reassessment of valuation drivers.

CCAP analyst rating: Links to earnings and strategic review for further context

Crescent’s Q4 2025 earnings call and the company’s review of dividend and fee structure add context to Raymond James’ move. See the earnings transcript and recap on Seeking Alpha for details on NII, NAV, dividend coverage, and strategic review source.

Final Thoughts

Raymond James’ Feb 26, 2026 note that maintains an Outperform rating but lowers the price target to $14 balances continued confidence with caution. The firm still prefers CCAP to peers, yet it trimmed upside. Investors should weigh the maintained positive rating against the smaller cushion to the new target.

Meyka AI rates CCAP with a grade of A. This grade factors S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Use our AI-powered market analysis as one input, and remember these grades are not guaranteed and we are not financial advisors.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.